2y6d › Citations

The discovery of MMP7 inhibitors exploiting a novel selectivity trigger.

Edman K, Furber M, Hemsley P, Johansson C, Pairaudeau G, Petersen J, Stocks M, Tervo A, Ward A, Wells E, Wissler L
ChemMedChem 6 769-73 (2011)
Cited: 27 times
EuropePMC logo PMID: 21520417

Reviews - 2y6d mentioned but not cited (2)

  1. Peripheral membrane associations of matrix metalloproteinases. Van Doren SR, Marcink TC, Koppisetti RK, Jurkevich A, Fulcher YG. Biochim Biophys Acta Mol Cell Res 1864 1964-1973 (2017)
  2. Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation. Fischer T, Riedl R. Molecules 24 (2019)

Articles - 2y6d mentioned but not cited (6)

  1. Remote homology and the functions of metagenomic dark matter. Lobb B, Kurtz DA, Moreno-Hagelsieb G, Doxey AC. Front Genet 6 234 (2015)
  2. Proapoptotic Effect and Molecular Docking Analysis of Curcumin-Resveratrol Hybrids in Colorectal Cancer Chemoprevention. Moreno-Q G, Herrera-R A, Yepes AF, Naranjo TW, Cardona-G W. Molecules 27 3486 (2022)
  3. Development of a Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-7/-13 Inhibitor. Fischer T, Riedl R. Molecules 22 (2017)
  4. Development of a Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-7/-13 Inhibitor. Fischer T, Riedl R. Molecules 22 E1548 (2017)
  5. Matrix Metalloprotease-7 Mediates Nucleolar Assembly and Intra-nucleolar Cleaving p53 in Gefitinib-Resistant Cancer Stem Cells. Yu WH, Wu E, Li Y, Hou HH, Yu SC, Huang PT, Kuo WH, Qi D, Yu CJ. iScience 23 101600 (2020)
  6. Prediction of Protein-compound Binding Energies from Known Activity Data: Docking-score-based Method and its Applications. Fukunishi Y, Yamashita Y, Mashimo T, Nakamura H. Mol Inform 37 e1700120 (2018)


Reviews citing this publication (3)

  1. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Sirica AE. Nat Rev Gastroenterol Hepatol 9 44-54 (2012)
  2. Could inhibition of metalloproteinases be used to block the process of metastasis? Alba J, Barcia R, Gutiérrez-Berzal J, Ramos-Martínez JI. Cell Biochem Funct 40 600-607 (2022)
  3. Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients. Chatterjee G, Pai T, Hardiman T, Avery-Kiejda K, Scott RJ, Spencer J, Pinder SE, Grigoriadis A. Breast Cancer Res. 20 143 (2018)

Articles citing this publication (16)

  1. Activation of the epithelial sodium channel (ENaC) by the alkaline protease from Pseudomonas aeruginosa. Butterworth MB, Zhang L, Heidrich EM, Myerburg MM, Thibodeau PH. J. Biol. Chem. 287 32556-32565 (2012)
  2. Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. Zhang Q, Liu S, Parajuli KR, Zhang W, Zhang K, Mo Z, Liu J, Chen Z, Yang S, Wang AR, Myers L, You Z. Oncogene 36 687-699 (2017)
  3. The Contribution of MMP-7 Genotypes to Colorectal Cancer Susceptibility in Taiwan. Yueh TC, Wu CN, Hung YW, Chang WS, Fu CK, Pei JS, Wu MH, Lai YL, Lee YM, Yen ST, Li HT, Tsai CW, Bau DT. Cancer Genomics Proteomics 15 207-212 (2018)
  4. Extracellular matrix gene expression profiling using microfluidics for colorectal carcinoma stratification. Hayes CJ, Dowling CM, Dwane S, McCumiskey ME, Tormey SM, Anne Merrigan B, Coffey JC, Kiely PA, Dalton TM. Biomicrofluidics 10 054124 (2016)
  5. The Association of MMP7 Genotype With Pterygium. Hu PS, Wang YC, Liao CH, Hsia NY, Wu MF, Yang JS, Yu CC, Chang WS, Bau DT, Tsai CW. In Vivo 34 51-56 (2020)
  6. A Comprehensive Pan-Cancer Analysis of the Tumorigenic Role of Matrix Metallopeptidase 7 (MMP7) Across Human Cancers. Meng N, Li Y, Jiang P, Bu X, Ding J, Wang Y, Zhou X, Yu F, Zhang Y, Zhang J, Xia L. Front Oncol 12 916907 (2022)
  7. Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model. Uddin MH, Al-Hallak MN, Khan HY, Aboukameel A, Li Y, Bannoura SF, Dyson G, Kim S, Mzannar Y, Azar I, Odisho T, Mohamed A, Landesman Y, Kim S, Beydoun R, Mohammad RM, Philip PA, Shields AF, Azmi AS. Clin Transl Med 13 e1513 (2023)
  8. A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells. Donnenberg VS, Luketich JD, Sultan I, Lister J, Bartlett DL, Ghosh S, Donnenberg AD. Front Immunol 14 1157697 (2023)
  9. Analysis of two birth tissues provides new insights into the epigenetic landscape of neonates born preterm. Wu Y, Lin X, Lim IY, Chen L, Teh AL, MacIsaac JL, Tan KH, Kobor MS, Chong YS, Gluckman PD, Karnani N. Clin Epigenetics 11 26 (2019)
  10. Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer. Liao CH, Chang WS, Tsai CW, Hu PS, Wu HC, Hsu SW, Chen GL, Yueh TC, Shen TC, Hsia TC, Bau DT. In Vivo 32 1045-1050 (2018)
  11. Bioinformatics and Molecular Insights to Anti-Metastasis Activity of Triethylene Glycol Derivatives. Malik V, Garg S, Afzal S, Dhanjal JK, Yun CO, Kaul SC, Sundar D, Wadhwa R. Int J Mol Sci 21 (2020)
  12. Detection of Matrix Metalloproteinase Activity by Bioluminescence via Intein-Mediated Biotinylation of Luciferase. Nguyen DL, Kim H, Kim D, Lee JO, Gye MC, Kim YP. Sensors (Basel) 18 (2018)
  13. Id4 Suppresses the Growth and Invasion of Colorectal Cancer HCT116 Cells through CK18-Related Inhibition of AKT and EMT Signaling. Chen HJ, Yu Y, Sun YX, Huang CZ, Li JY, Liu F, Guo GX, Ye YB. J Oncol 2021 6660486 (2021)
  14. Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer. Szarvas T, Sevcenco S, Módos O, Keresztes D, Nyirády P, Csizmarik A, Ristl R, Puhr M, Hoffmann MJ, Niedworok C, Hadaschik B, Maj-Hes A, Shariat SF, Kramer G. BJU Int. 122 695-704 (2018)
  15. Preclinical Identification of Sulfasalazine's Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling. Leung WH, Shih JW, Chen JS, Mokgautsi N, Wei PL, Huang YJ. Biomedicines 10 377 (2022)
  16. Synovial Tissue Proteins and Patient-Specific Variables as Predictive Factors for Temporomandibular Joint Surgery. Ulmner M, Sugars R, Naimi-Akbar A, Tudzarovski N, Kruger-Weiner C, Lund B. Diagnostics (Basel) 11 (2020)


Quick links